SN
MRNA icon

Sittner & Nelson’s Moderna MRNA Stock Holding History

Sittner & Nelson’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.5K Sell
650
-40
-6% -$2.07K 0.01% 311
2026
Q1 		$35.1K Hold
690
– – 0.01% 325
2025
Q4 		$28.3K Hold
690
– – 0.01% 316
2025
Q3 		$17.8K Hold
690
– – 0.01% 330
2025
Q2 		$19K Hold
690
– – 0.01% 326
2025
Q1 		$19.6K Hold
690
– – 0.01% 314
2024
Q4 		$28.7K Sell
690
-300
-30% -$14.3K 0.01% 260
2024
Q3 		$66.2K Hold
990
– – 0.03% 207
2024
Q2 		$118K Sell
990
-150
-13% -$19K 0.06% 148
2024
Q1 		$121K Buy
1,140
+50
+5% +$5.04K 0.06% 150
2023
Q4 		$108K Buy
1,090
+510
+88% +$42.9K 0.06% 153
2023
Q3 		$59.9K Hold
580
– – 0.03% 187
2023
Q2 		$70.5K Hold
580
– – 0.04% 179
2023
Q1 		$89.1K Hold
580
– – 0.05% 168
2022
Q4 		$104K Hold
580
– – 0.06% 162
2022
Q3 		$69K Hold
580
– – 0.05% 185
2022
Q2 		$83K Buy
580
+60
+12% +$8.58K 0.05% 165
2022
Q1 		$90K Buy
520
+120
+30% +$20.2K 0.05% 159
2021
Q4 		$102K Buy
400
+50
+14% +$14.6K 0.06% 145
2021
Q3 		$135K Sell
350
-300
-46% -$111K 0.09% 117
2021
Q2 		$153K Hold
650
– – 0.11% 104
2021
Q1 		$85K Hold
650
– – 0.06% 136
2020
Q4 		$68K Buy
+650
New +$65.8K 0.06% 140

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Sittner & Nelson's MRNA Position: Q2 2026 in Review

Sittner & Nelson reduced its Moderna (MRNA) stake by 5.8% in Q2 2026, selling an estimated $2.07K and leaving 650 shares worth $45.5K. The position accounts for 0.01% of the portfolio, ranked #311.

Sittner & Nelson first reported a position in MRNA in Q4 2020 and has held it in 23 quarters since. The position peaked at $153K in Q2 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Sittner & Nelson held 650 shares of Moderna worth $45.5K as of Q2 2026.
  • Sittner & Nelson sold 40 Moderna shares in Q2 2026, an estimated $2.07K.
  • Moderna made up 0.01% of Sittner & Nelson's portfolio in Q2 2026, its #311 holding.
  • Sittner & Nelson first reported a position in Moderna in Q4 2020 and has held it in 23 quarters since.
  • Sittner & Nelson's Moderna position peaked at $153K in Q2 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Sittner & Nelson's 13F filing for Q2 2026, filed 7 Aug 2026.